Management of myocardial infarction: the proper priorities
Key result
Direct percutaneous transluminal coronary angioplasty for acute myocardial infarction lacks sufficient data to prove superiority over thrombolysis, highlighting the need for early pre-hospital therapy.
Why the study?
Does direct percutaneous transluminal coronary angioplasty improve survival compared to thrombolysis in patients with evolving myocardial infarction?
Population
Patients with evolving acute myocardial infarction
Comparison
Direct percutaneous transluminal coronary… vs Thrombolysis and very early pre-hospital therapy
Design
Editorial
Authors
Discussion
Loading...
Member takes
Implication
The authors argue against the uncritical adoption of direct PTCA for acute myocardial infarction, emphasizing the need to prioritize early pre-hospital therapy to improve survival.
Structured PICO
Does direct percutaneous transluminal coronary angioplasty improve survival compared to thrombolysis in patients with evolving myocardial infarction?
P
Population
Patients with evolving acute myocardial infarction
I
Intervention
Direct percutaneous transluminal coronary angioplasty (PTCA) and stenting
C
Comparator
Thrombolysis and very early pre-hospital therapy
O
Outcome
Survival
The authors argue against the uncritical adoption of direct PTCA for acute myocardial infarction, emphasizing the need to prioritize early pre-hospital therapy to improve survival.
Cite This Study
Simoons et al. (1997) conducted an editorial in acute myocardial infarction. direct percutaneous transluminal coronary angioplasty vs. thrombolysis was evaluated. Direct percutaneous transluminal coronary angioplasty for acute myocardial infarction lacks sufficient data to prove superiority over thrombolysis, highlighting the need for early pre-hospital therapy.